Request Demo
Last update 20 Mar 2025
Dexamethasone/Levofloxacin
Last update 20 Mar 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms levofloxacin-dexamethasone, 左氧氟沙星地塞米松 |
Action inhibitors, agonists, modulators |
Mechanism Bacterial DNA gyrase inhibitors(Bacterial DNA gyrase inhibitors), GR agonists(Glucocorticoid receptor agonists), Top II modulators(Topoisomerase II modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date Germany (28 May 2020), |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC18H22FN3O5 |
InChIKeyQEHPHWRZQAZOTI-PPHPATTJSA-N |
CAS Registry138199-71-0 |
Related
1
Clinical Trials associated with Dexamethasone/LevofloxacinNCT03739528
An International, Multicenter, Randomized, Blinded-assessor, Parallel-group Clinical Study Comparing Eye Drops of Combined LEvofloxAcin + DExamethasone foR 7 Days Followed by Dexamethasone Alone for an Additional 7 Days vs. Tobramycin + Dexamethasone for 14 Days for the Prevention and Treatment of Inflammation and Prevention of Infection Associated With Cataract Surgery in Adults - LEADER 7
100 Clinical Results associated with Dexamethasone/Levofloxacin
Login to view more data
100 Translational Medicine associated with Dexamethasone/Levofloxacin
Login to view more data
100 Patents (Medical) associated with Dexamethasone/Levofloxacin
Login to view more data
100 Deals associated with Dexamethasone/Levofloxacin
Login to view more data
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Cataract | Canada | 12 Dec 2023 | |
| Eye Infections, Bacterial | Canada | 12 Dec 2023 | |
| Inflammation | Canada | - | |
| Ocular inflammation | Israel | - |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Ocular inflammation | NDA/BLA | China | 10 Nov 2022 | |
| Ocular inflammation | NDA/BLA | China | 10 Nov 2022 | |
| Ocular inflammation | NDA/BLA | China | 10 Nov 2022 | |
| Eye Infections | Phase 2 | - | - | |
| Cataract | Phase 1 | Italy | 03 Sep 2018 | |
| Infectious Diseases | Phase 1 | Italy | 03 Sep 2018 | |
| Inflammation | Phase 1 | Italy | 03 Sep 2018 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 3 | 808 | (Levofloxacin + Dexamethasone Followed by Dexamethasone) | dnhqgudnej(ocykfgqwyu) = qjsmvcdqbq lkzextbmxt (fbfyvymizq, motspvnaio - clbokloomw) View more | - | 18 Aug 2020 | ||
(Tobramycin + Dexamethasone) | dnhqgudnej(ocykfgqwyu) = vcpqixoask lkzextbmxt (fbfyvymizq, dirxoagxpb - lxeunlsnvw) View more |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free